These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 26814210)
1. High-fat diets exaggerate endocrine and metabolic phenotypes in a rat model of DHEA-induced PCOS. Zhang H; Yi M; Zhang Y; Jin H; Zhang W; Yang J; Yan L; Li R; Zhao Y; Qiao J Reproduction; 2016 Apr; 151(4):431-41. PubMed ID: 26814210 [TBL] [Abstract][Full Text] [Related]
2. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Lai H; Jia X; Yu Q; Zhang C; Qiao J; Guan Y; Kang J Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714 [TBL] [Abstract][Full Text] [Related]
3. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome. Seow KM; Ting CH; Huang SW; Ho LT; Juan CC Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654 [TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model. He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598 [TBL] [Abstract][Full Text] [Related]
5. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633 [TBL] [Abstract][Full Text] [Related]
6. Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota. Wang X; Gu L; Zhang Y; Xiong C; Peng Y; Ding X Front Endocrinol (Lausanne); 2022; 13():1030151. PubMed ID: 36619569 [TBL] [Abstract][Full Text] [Related]
7. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model. Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534 [TBL] [Abstract][Full Text] [Related]
8. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice. Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175 [TBL] [Abstract][Full Text] [Related]
9. High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats. Patel R; Shah G Reproduction; 2018 Feb; 155(2):141-151. PubMed ID: 29196492 [TBL] [Abstract][Full Text] [Related]
10. DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway. Wang D; Wang W; Liang Q; He X; Xia Y; Shen S; Wang H; Gao Q; Wang Y J Ovarian Res; 2018 Jan; 11(1):6. PubMed ID: 29321035 [TBL] [Abstract][Full Text] [Related]
11. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003 [TBL] [Abstract][Full Text] [Related]
12. The effect of cinnamon on polycystic ovary syndrome in a mouse model. Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496 [TBL] [Abstract][Full Text] [Related]
13. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome. Mahmoud AA; Elfiky AM; Abo-Zeid FS Steroids; 2022 Jan; 177():108936. PubMed ID: 34752810 [TBL] [Abstract][Full Text] [Related]
14. Brown adipose tissue transplantation ameliorates polycystic ovary syndrome. Yuan X; Hu T; Zhao H; Huang Y; Ye R; Lin J; Zhang C; Zhang H; Wei G; Zhou H; Dong M; Zhao J; Wang H; Liu Q; Lee HJ; Jin W; Chen ZJ Proc Natl Acad Sci U S A; 2016 Mar; 113(10):2708-13. PubMed ID: 26903641 [TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats. Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058 [TBL] [Abstract][Full Text] [Related]
16. Assessment of growth and metabolism characteristics in offspring of dehydroepiandrosterone-induced polycystic ovary syndrome adults. Huang Y; Gao JM; Zhang CM; Zhao HC; Zhao Y; Li R; Yu Y; Qiao J Reproduction; 2016 Dec; 152(6):705-714. PubMed ID: 27798284 [TBL] [Abstract][Full Text] [Related]
17. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats. Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684 [TBL] [Abstract][Full Text] [Related]
18. A Rat Model of Polycystic Ovary Syndrome with Insulin Resistance Induced by Letrozole Combined with High Fat Diet. Wang MX; Yin Q; Xu X Med Sci Monit; 2020 May; 26():e922136. PubMed ID: 32448863 [TBL] [Abstract][Full Text] [Related]
19. Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway Zhou J; Tan Y; Wang X; Zhu M Aging (Albany NY); 2021 Feb; 13(5):7084-7095. PubMed ID: 33638949 [TBL] [Abstract][Full Text] [Related]
20. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats. Jang M; Lee MJ; Lee JM; Bae CS; Kim SH; Ryu JH; Cho IH PLoS One; 2014; 9(2):e87623. PubMed ID: 24520334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]